GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lexagene Holdings Inc (OTCPK:LXXGQ) » Definitions » Asset Turnover

Lexagene Holdings (Lexagene Holdings) Asset Turnover : 0.01 (As of Nov. 2022)


View and export this data going back to 2017. Start your Free Trial

What is Lexagene Holdings Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Lexagene Holdings's Revenue for the three months ended in Nov. 2022 was $0.04 Mil. Lexagene Holdings's Total Assets for the quarter that ended in Nov. 2022 was $3.84 Mil. Therefore, Lexagene Holdings's Asset Turnover for the quarter that ended in Nov. 2022 was 0.01.

Asset Turnover is linked to ROE % through Du Pont Formula. Lexagene Holdings's annualized ROE % for the quarter that ended in Nov. 2022 was -350.40%. It is also linked to ROA % through Du Pont Formula. Lexagene Holdings's annualized ROA % for the quarter that ended in Nov. 2022 was -174.68%.


Lexagene Holdings Asset Turnover Historical Data

The historical data trend for Lexagene Holdings's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lexagene Holdings Asset Turnover Chart

Lexagene Holdings Annual Data
Trend Mar13 Mar14 Mar15 Feb16 Feb17 Feb18 Feb19 Feb20 Feb21 Feb22
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 0.01 0.01

Lexagene Holdings Quarterly Data
Feb18 May18 Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 - - 0.01 0.01

Competitive Comparison of Lexagene Holdings's Asset Turnover

For the Medical Devices subindustry, Lexagene Holdings's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lexagene Holdings's Asset Turnover Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lexagene Holdings's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Lexagene Holdings's Asset Turnover falls into.



Lexagene Holdings Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Lexagene Holdings's Asset Turnover for the fiscal year that ended in Feb. 2022 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Feb. 2022 )/( (Total Assets (A: Feb. 2021 )+Total Assets (A: Feb. 2022 ))/ count )
=0.075/( (13.195+8.198)/ 2 )
=0.075/10.6965
=0.01

Lexagene Holdings's Asset Turnover for the quarter that ended in Nov. 2022 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Nov. 2022 )/( (Total Assets (Q: Aug. 2022 )+Total Assets (Q: Nov. 2022 ))/ count )
=0.043/( (4.195+3.49)/ 2 )
=0.043/3.8425
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Lexagene Holdings  (OTCPK:LXXGQ) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Lexagene Holdings's annulized ROE % for the quarter that ended in Nov. 2022 is

ROE %**(Q: Nov. 2022 )
=Net Income/Total Stockholders Equity
=-6.712/1.9155
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-6.712 / 0.172)*(0.172 / 3.8425)*(3.8425/ 1.9155)
=Net Margin %*Asset Turnover*Equity Multiplier
=-3902.33 %*0.0448*2.006
=ROA %*Equity Multiplier
=-174.68 %*2.006
=-350.40 %

Note: The Net Income data used here is four times the quarterly (Nov. 2022) net income data. The Revenue data used here is four times the quarterly (Nov. 2022) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Lexagene Holdings's annulized ROA % for the quarter that ended in Nov. 2022 is

ROA %(Q: Nov. 2022 )
=Net Income/Total Assets
=-6.712/3.8425
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-6.712 / 0.172)*(0.172 / 3.8425)
=Net Margin %*Asset Turnover
=-3902.33 %*0.0448
=-174.68 %

Note: The Net Income data used here is four times the quarterly (Nov. 2022) net income data. The Revenue data used here is four times the quarterly (Nov. 2022) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Lexagene Holdings Asset Turnover Related Terms

Thank you for viewing the detailed overview of Lexagene Holdings's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Lexagene Holdings (Lexagene Holdings) Business Description

Traded in Other Exchanges
N/A
Address
500 Cummings Center, Suite 4550, Beverly, MA, USA, 01915
Lexagene Holdings Inc is a molecular diagnostics company that develops molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The MiQLab system delivers sensitivity, specificity, and breadth of detection and can return results in approximately two hours. The unique open-access feature is designed for custom testing so that end-users can load their own real-time PCR assays onto the instrument to target any genetic target of interest.

Lexagene Holdings (Lexagene Holdings) Headlines

From GuruFocus

LexaGene Reduces Time-to-Result by ~35%

By PurpleRose PurpleRose 08-10-2022

LexaGene Announces Management Cease Trade Order

By GlobeNewswire GlobeNewswire 06-30-2022

LexaGene Provides Update on BioPharma Sector

By Stock market mentor Stock market mentor 02-08-2023

LexaGene Files for Chapter 7 Bankruptcy

By sperokesalga sperokesalga 02-24-2023

LexaGene Closes Secured Convertible Note Transaction

By Value_Insider Value_Insider 11-01-2022